Deutsche Bank analyst George Hill maintained a Hold rating on Walgreens Boots Alliance (WBA – Research Report) yesterday and set a price target of $46.00. The company’s shares closed last Monday at $43.40, close to its 52-week low of $43.18.
According to TipRanks.com, Hill is a 4-star analyst with an average return of 8.3% and a 56.5% success rate. Hill covers the Healthcare sector, focusing on stocks such as Molina Healthcare, 1Life Healthcare, and Cardinal Health.
Currently, the analyst consensus on Walgreens Boots Alliance is a Hold with an average price target of $49.57, which is a 13.1% upside from current levels. In a report issued on April 1, Truist Financial also maintained a Hold rating on the stock with a $50.00 price target.
Walgreens Boots Alliance’s market cap is currently $37.86B and has a P/E ratio of 6.05.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Retail pharmacy leader Walgreens Boots Alliance (NASDAQ:WBA) operates through its namesake brand Walgreens in the U.S. and Boots in the U.K. In addition, it owns retail and business brands including the No7 Beauty Company, Duane Reade, Ahumada in Chile, and Benavides in Mexico. The company also targets equity investments in healthcare, pharmacy, and retail and has a presence in over 25 countries with more than 450,000 employees.
Read More on WBA:
- Prometheus Biosciences (RXDX) Receives a New Rating from BTIG
- BTIG Thinks Gracell Biotechnologies’ Stock is Going to Recover
- BTIG Remains a Buy on Redbox Entertainment (RDBX)
- BTIG Maintains Their Buy Rating on Silence Therapeutics (SLN)
- BTIG Thinks Freeline Therapeutics Holdings’ Stock is Going to Recover